The 26 million: how to care for people living with long-term health conditions
Dec 07, 2023, 02:34 PM
How should we think of the 26 million people in the UK living with a long-term health condition? Under the current system, only a handful of long-term conditions are prioritised. This leads to a huge strain on NHS resources and capacity later down the road, as long-term health conditions comprise 50 per cent of all GP appointments and 70 per cent hospital bed days. What's more, 2.5 million working-age adults are out of the labour market because of long-term sickness.
How do we better make the NHS – and politicians – accountable to these patients? With treatment and care of patients with long term conditions estimated to take up around £7 in every £10 of total health and social care expenditure, we urgently need fresh thinking to grasp the scale and scope of this challenge.
Isabel Hardman hosts this special episode of Spectator Briefings with a panel of expert guests:
Guy Opperman MP, Minister for Employment
Lord Nick Markham, Parliamentary Under Secretary of State (Minister for the Lords) - DHSC
Richard Sloggett, Founder – Future Health Research
Georgina Carr, Chief Executive – Neurological Alliance
Todd Manning, VP and General Manager – Abbvie UK
Developed in association with and funded by AbbVie.
How do we better make the NHS – and politicians – accountable to these patients? With treatment and care of patients with long term conditions estimated to take up around £7 in every £10 of total health and social care expenditure, we urgently need fresh thinking to grasp the scale and scope of this challenge.
Isabel Hardman hosts this special episode of Spectator Briefings with a panel of expert guests:
Guy Opperman MP, Minister for Employment
Lord Nick Markham, Parliamentary Under Secretary of State (Minister for the Lords) - DHSC
Richard Sloggett, Founder – Future Health Research
Georgina Carr, Chief Executive – Neurological Alliance
Todd Manning, VP and General Manager – Abbvie UK
Developed in association with and funded by AbbVie.